Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hermans

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
JHEP Reports : Innovation in Hepatology|May 2, 2024
Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cellsAnna H Mooney, Sarah L Draper, Olivia K Burn, et al.
European Journal of Heart Failure|November 28, 2012
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriersIngrid A W van Rijsingen, Eline A Nannenberg, Eloisa Arbustini, et al.
Organic & Biomolecular Chemistry|January 19, 2019
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonistBenjamin J Compton, Kathryn J Farrand, Ching-Wen Tang, et al.
Hemasphere|February 27, 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease ProphylaxisSjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, et al.
Iscience|February 27, 2023
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsIsabelle Montgomerie, Thomas W Bird, Olga R Palmer, et al.
Cancer Medicine|April 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modelingSjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, et al.
Cell Reports|February 13, 2025
Mechanistic insight into the induction of liver tissue-resident memory CD8<sup>+</sup> T cells by glycolipid-peptide vaccinationYu Cheng Chua, Sarah L Draper, Shirley Le, et al.
British Journal of Haematology|May 26, 2025
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patientsSjoerd J F Hermans, Jurjen Versluis, Erik D van Werkhoven, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2023
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanomaNathaniel Dasyam, Katrina J Sharples, Catherine Barrow, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
JHEP Reports : Innovation in Hepatology|May 2, 2024
Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cellsAnna H Mooney, Sarah L Draper, Olivia K Burn, et al.
European Journal of Heart Failure|November 28, 2012
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriersIngrid A W van Rijsingen, Eline A Nannenberg, Eloisa Arbustini, et al.
Organic & Biomolecular Chemistry|January 19, 2019
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonistBenjamin J Compton, Kathryn J Farrand, Ching-Wen Tang, et al.
Hemasphere|February 27, 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease ProphylaxisSjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, et al.
Iscience|February 27, 2023
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsIsabelle Montgomerie, Thomas W Bird, Olga R Palmer, et al.
Cancer Medicine|April 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modelingSjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, et al.
Cell Reports|February 13, 2025
Mechanistic insight into the induction of liver tissue-resident memory CD8<sup>+</sup> T cells by glycolipid-peptide vaccinationYu Cheng Chua, Sarah L Draper, Shirley Le, et al.
British Journal of Haematology|May 26, 2025
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patientsSjoerd J F Hermans, Jurjen Versluis, Erik D van Werkhoven, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2023
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanomaNathaniel Dasyam, Katrina J Sharples, Catherine Barrow, et al.
Pageof 13